Literature DB >> 10613593

Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.

D Brasanac1, J Marković-Lipkovski, J Hadzi-Djokić, G A Müller, C A Müller.   

Abstract

Cryostat sections of 37 renal cell carcinomas (RCC)--25 clear cell type, 10 granular and 2 chromophobe--were studied with indirect immunoperoxidase method applying monoclonal antibodies (MoAb) to HLA-DR, -DP and -DQ antigens for analysis of HLA class II antigens, and anti-CD14, -CD3, -CD4 and -CD8 MoAb for tumor infiltrating mononuclear cells (TIM). Number of positive cells was estimated semiquantitatively and results of immunohistochemical investigation were correlated with clinical (patient age and sex, tumor size and TNM stage) and histopathological (cytology, histology, grade) characteristics of RCC. All RCC expressed HLA-DR, 92% -DQ and 73% -DP antigens with level of expression in hierarchy- DR>-DQ>-DP, but no statistically important correlation could be established with any of the histopathological or clinical parameters analyzed. Monocytes were more abundant than T lymphocytes and CD4+ than CD8+ T cells, whereas tumors with T lymphocyte predominance and approximately equal number of CD4+ and CD8+ T cells had greatest average diameter. Inadequate activation of T lymphocytes by tumor cells (despite capability of antigen presentation) could be the reason for association of parameters which indicates more aggressive tumor behavior with aberrant HLA class II antigen expression on RCC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10613593

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  6 in total

1.  The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.

Authors:  Erkan Yilmaz; Arman Çekmen; Emre Akkuş; Bülent Önal; Ali Uğur Özalp; Vural Solok; Ergun Erdoğan; Bülent Eren
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

2.  Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Alexey A Leontovich; Svetomir N Markovic
Journal:  Melanoma Res       Date:  2016-10       Impact factor: 3.599

Review 3.  The immunoregulatory mechanisms of carcinoma for its survival and development.

Authors:  Caigan Du; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2011-01-21

Review 4.  The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review.

Authors:  Yu Liu; Peixin Chen; Hao Wang; Shengyu Wu; Sha Zhao; Yayi He; Caicun Zhou; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2021-02

5.  Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma.

Authors:  Thanaa el-A Helal; Ali E Khalf Alla; Mohamed A Laban; Remon M Fahmy
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

6.  Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.

Authors:  Tomohide Tatsumi; Lisa S Kierstead; Elena Ranieri; Loreto Gesualdo; Francesco P Schena; James H Finke; Ronald M Bukowski; Jan Mueller-Berghaus; John M Kirkwood; William W Kwok; Walter J Storkus
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.